EyePoint (EYPT) stock rose 10% after the company reported six-month results from a phase 2 study of its drug Duravyu in the treatment of diabetic macular edema. Read more here.

Good (HDL) cholesterol may raise glaucoma risk, while ‘bad’ (LDL) cholesterol could lower the risk of vision loss from ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Drug distributor Cencora raised its fiscal 2025 profit forecast on Wednesday, driven by robust demand for expensive specialty medicines.

THIRUVANANTHAPURAM: Chief Minister Pinarayi Vijayan on Wednesday released a textbook on diabetes management, published by ...

The World Health Organization reports that around 2.2 billion people struggle with vision problems such as near-sightedness ...

The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...

The cholesterol that's good for your heart health might be bad for your eye health and vice versa, a new study says.

A small percentage of patients taking GLP-1 medications have experienced vision problems, but a direct causal link with the ...

In-Home Preventive Care Screening Programs Close Critical HEDIS Gaps in Care Measures & Improve Compliance Rates Through Multi-Cha ...

Musician, actor, businessman and author Phillip Morris, from Newport, died following the weight loss surgery which he wanted ...